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1 Department of General, Visceral and Oncological Surgery, Wilhelminenspital, Vienna, Austria, 2 Department of Surgery and 
Center for Minimally Invasive Surgery, Vivantes Hospital, Berlin, Germany
introduction: In the field of hernia prevention, the prophylactic mesh-reinforcement 
of stoma-sites is one of the most controversially discussed issues. The incidence of 
parastomal hernias in the literature reported to be up to 48.1% after end colostomy and 
up to 30.8% after loop of colostomy, but still remains uncertain due to diagnostic variety 
of clinical or radiological methods, heterogeneous patient groups and variable follow-up 
intervals. Anyway, the published data regarding the use of synthetic or bio-prostethic 
meshes in the prevention of parastomal hernia at the primary operation are very scarce.
Methods: A literature search of the Medline database in terms of biological prophylactic 
mesh implantation in stoma creation identified six systematic reviews, two randomized 
controlled trials (RCT), two case-controlled studies, and one technical report.
Results: In a systematic review focusing on the prevention of parastomal hernia 
including only RCTs encompassing one RCT using bio-prosthetic mesh the incidence of 
herniation was 12.5% compared to 53% in the control group (p < 0.0001). In one RCT 
and two case-control studies, respectively, there was a significant smaller incidence of 
parastomal herniation as well as a similar complication rate compared to the control 
group. Only in one RCT, no significant difference regarding the incidence of parastomal 
hernia was reported with comparable complication rates.
Conclusion: Thus, so far two RCT and two case-control studies are published with pro-
phylactic bio-prosthetic reinforcement in stoma sites. The majority revealed significant 
better results in terms of parastomal herniation and without any mesh-related compli-
cations in comparison to the non mesh group. Further, multicenter RCT are required to 
achieve a sufficient level of recommendation.
Keywords: parastomal hernia, parastomal hernia repair, parastomal hernia prevention, biologic mesh, bio mesh, 
bio-prostethic mesh
iNTRODUCTiON
The BioMesh Study Group has set itself the task of identifying the best way to use biological meshes 
for various indications. The first step toward achieving that goal is to compile systematic reviews of 
the different indications on the basis of the existing literature. The available literature sources will be 
evaluated in accordance with the Oxford Centre for Evidence-based Medicine-Levels of Evidence 
(March 2009). Next, based on the review findings, corresponding Statements and Recommendations 
are to be formulated in a Consensus Conference for the use of biological meshes for the different 
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indications. The findings of the Consensus Conference are then 
to be summarized for a joint publication. This present publication 
is part of the project undertaken by the BioMesh Study Group.
In the field of hernia prevention, the prophylactic mesh-
reinforcement of stoma-sites is one of the most controversially 
discussed issues. The exact incidence of parastomal hernias 
remains uncertain due to diagnostic variety of clinical or radio-
logical methods like ultrasound and computed tomography, 
heterogeneous patient groups, and variable follow-up intervals 
(1). Based on a meta-analysis by Carne et al. (2), the incidence for 
parastomal hernia ranges from 1.8 to 28.3% for end ileostomies 
and 0–6.2% for loop ileostomies. In case of end colostomy, the 
hernia rates are reported as 4.0–48.1% and in case of loop colos-
tomy, the hernia rates are 0–30.8% after 10-year follow up. In a life 
time analysis of stomal complications such as bulge, abdominal 
discomfort, abdominal pain, constipation, incarceration, ileus, 
and parastomal herniation following colostomy can be occur in a 
time frame of up to 20 years postoperatively (3). It seems that one 
of the most successful prevention of stoma site hernias is the use 
of a prophylactic mesh. The risk of colostomy herniation seems to 
be doubled in comparison to an ileostomy. The relation of a larger 
diameter of the trephine to the abdominal wall defect in case of 
colostomy creation might be the main reason. There are differ-
ent surgical options for parastomal hernia repair. In the current 
review of Aquina et al. (4) the cumulative recurrence rates in the 
literature for open surgery are reported to be 67.6% after suture 
repair, 18.2%, after mesh only repair and 9.6% after retromuscular 
mesh repair. For laparoscopic surgery recurrence rates were 30% 
after mesh repair by keyhole technique, 8.1% by Sugarbaker tech-
nique and 2.1% after sandwich technique respectively. In another 
review concerning the use of biologic grafts for parastomal hernia 
repair by Slater et  al. (5), four retrospective studies (combined 
enrollment of 57 patients) obtained a cumulative recurrence 
rate 15.7% [95% confidence interval (CI) 7.8–25.9] and wound-
related complications in 26.2% (95% CI 14.7–39.5). No mortality 
or graft infections were reported.
But anyhow following questions still remain: first, the selec-
tion of mesh type and location at the primary operation for the 
prevention of hernia development and second is there any indica-
tion for the use of bio mesh in a clean contaminated field.
MeTHODS
A literature search of the Medline database using the PubMed 
search engine, using the keywords (parastomal hernia OR par-
astomal hernia repair OR parastomal hernia prevention AND 
biologic mesh AND biomesh AND bio mesh) returned 236 hits 
up to June 2015. Titles and abstracts were scrutinized on the use 
of prophylactic biologic mesh reinforcement of the stoma site at 
the primary operation. The full text of 25 articles was assessed 
and 11 relevant papers were identified including six systematic 
reviews (4, 6–10), two randomized controlled studies (RCT) 
(11, 12), two case-controlled studies (13, 14), and one technical 
report (14). A summary of study characteristics and outcomes is 
presented in Table 1. Qualitative assessment of all included stud-
ies was performed using the Oxford Centre for Evidence-Based 
Medicine 2009 levels of evidence. TA
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ReSULTS
The reviews of Aquina et al., Hotouras et al., Shabbir et al., Sajid 
et  al., Wijeyekoon et  al., and Tam et  al. (4, 6–10) all focused 
on parastomal hernia prevention by the placement of a mesh 
(synthetic and biological) at the primary operation. Aquina et al. 
(4) reported a cumulative incidence of parastomal hernia rate of 
10.7% including the RCT of Hammond et al. (11) using a biologic 
mesh (Permacol). In the systematic review of Shabbir et al. (7), 
three RCT [Hammond et al., Jänis et al., and Serra-Aracil et al. 
(11, 15, 16)] were enclosed. The analysis of the three RCT com-
prising a total of 128 patients (64 with mesh, 64 without mesh) 
revealed a hernia incidence of 12.5% compared to 53% in the con-
trol group [risk ratio, 95%, CI, 0.25 (0.13, 0.48), p < 0.0001] in a 
follow up period of 7–83 months. Two of the studies (11, 16) used 
clinical and radiological examinations. Concerning mesh-related 
morbidity, no difference was detected. The systematic review of 
Sajid et al., Wijeyekoon et al., and Tam et al. (7–9) all including 
the same RCT (11, 15, 16) obtained identical results.
In 2008, the first RCT focusing on the use of biological mesh 
for parastomal hernia prevention was published by Hammond 
et  al. (11). Twenty patients undergoing a defunctioning stoma 
operation were randomized to an interventional group with 
reinforcement by porcine-derived, acellular dermal sheet, cross-
linked acellular dermal sheet (Permacol, Tissue science labora-
tories, Aldershot, Hants, UK) or a conventional group without 
mesh. The trephine of the abdominal wall including the rectus 
sheath was defined by 2 cm × 2 cm. The biological mesh measur-
ing 10 cm × 10 cm was supplied with a center keyhole of 2 cm and 
positioned between posterior layer of the rectus sheath and the 
peritoneal membrane – described as pre-peritoneal position and 
fixated by interrupted 3/0 prolene sutures to the rectus sheath by 
an inner and outer suturing at four positions.
The patient controls were performed at the time of stoma 
reversal or in cases of non-stoma reversal, at 12  months. At a 
median follow up of 6.5  months, three patients suffered from 
a parastomal hernia in the control group and no patient in the 
treatment group. Stoma site ultrasound assessment was per-
formed in 7 of 10 patients in the treatment group and 9 of 10 in 
the control group. There were no detected differences concerning 
the infection signs or other complications. The shortcomings of 
this randomized controlled phase 1 study are the low number of 
patients enrolled, the short follow-up period and an unexpected 
very high percentage of stoma site hernias in the control group in 
comparison to the published literature (2).
The second study selected in this review published in 2012 is 
a retrospective case-control study by Figel et al. (13). A biologic 
mesh derived from porcine submucosa (Surgisis EXL, Cook 
Surgical, Bloomington, IN, USA) and non-cross-linked with a 
size of 13 cm × 22 cm was placed at the time of creation of an 
intestinal end stoma in a Sugarbaker position (12 patients) and in 
keyhole-technique (four patients). Sixteen patients were enrolled. 
No mesh related complications and no parastomal hernias were 
detected in a median follow-up of 38  months. This study con-
firmed the safety, efficacy, and cost-effectiveness, respectively, of 
prophylactic bio-prosthetic mesh reinforcement at the time-point 
of permanent stoma creation.
In the year 2014, another prospective, multicenter, rand-
omized, controlled, double-blinded study of non-cross-linked 
porcine acellular dermal matrix (PADM; Strattice, LifeCell 
Corporation, Branchburg, NJ) in patients undergoing elective 
surgery for permanent end stoma (71 colostomies, 42 ileosto-
mies) was published by Fleshman et al. (12). Fifty-five patients 
were treated with the use of PADM in a size of 6 cm × 6 cm or 
8 cm × 8 cm (median size after trimming 4.8 cm × 4.8 cm) with 
a cruciate incision of 2 cm for the bowel passage (incision was 
enlarged in 78.2%) in a retro-muscular sublay position using 
no fixation. The control group consisted of 58 patients without 
mesh reinforcement. Intraoperative complications, blood loss, 
and quality of life-scores were without significant differences in 
either group. The postoperative investigations were performed 
by a blinded assessor and an abdominal CT (11 patients) was 
followed in case of suspected herniation at the stoma site. The 
incidence of parastomal hernias in a follow up of 24 months was 
12.2% in the PADM-group and 13.2% in the controls without 
significant difference. The ostomy circumference in the PADM 
group was significant larger (6.4 ± 3.9 vs. 4.8 ± 2.9 cm; p = 0.002) 
compared to the control group, which may be a predisposition 
for the development of a parastomal hernia and represents a 
potential bias of the study. In a letter to the editor, Hontouras 
(17) discussed the important role and risk of oversized stoma 
aperture for the development of a hernia. Based on the study of 
Pilgrim et al. (18), a stoma aperture >35 mm is an independent 
risk factor for hernia development – increasing by 10% for every 
millimeter increase in size. In summary, the RCT of Fleshmann 
et al. confirms the safety of prophylactic biological reinforcement. 
However, based on the results of parastomal hernia incidence in 
comparison to the control group, no recommendation for the use 
of bio-prosthesis can be given.
Recently published in 2015, Williams et  al. (14) reported 
a case-controlled pilot study based on a stapled mesh stoma 
reinforcement technique (SMART), which was already intro-
duced in 2011 (19). A special designed circular stapler gun 
(Compact™, Frankemann International Limited) was used 
in combination with a porcine-derived cross-linked acellular 
dermal sheet (Permacol™, Covidien plc, 20 Lower Hatch St, 
Dublin 2, Ireland), which is configured in a circular design with 
a diameter of 7 cm. After excising, a cylinder of abdominal wall 
and subcutaneous fat a cruciate incision of the rectus sheath 
is performed. The knife diameter used (17, 21, or 24  mm) is 
dependent on the diameter of the bowel used to be traverse the 
stoma trephine. The shaft of the anvil is delivered through the 
posterior rectus sheath and mated with the trocar of the circular 
stapling device after preloading with the mesh. The circular 
stapling device is closed, fired, and removed, encompassing 
a disc of mesh, posterior rectus sheath and peritoneum and 
leaving a precise reinforced stapled trephine. Finally, the outer 
mesh circumference is sutured to the anterior rectus sheath. 
Twentytwo patients were included and received stoma forma-
tion with SMART-technique and another 11 were assigned to the 
control group without reinforcement of the stoma site (18 open: 
4 laparoscopic; 11 ileostomies: 11 colostomies). All SMART sto-
mas were fashioned using a circular stapler with a 24-mm knife 
diameter. Patients with either complications from a pre-existing 
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stoma (n =  15)  –  large parastomal hernia unsuitable for local 
repair (n =  6) or recurrent herniation as a result of previous 
repair (n = 9) or underlying conditions (n = 7) – such as obesity, 
asthma, corticosteroid use, collagen disorder or combination of 
these respectively underwent a resiting SMART-procedure at the 
index operation.
There were no intraoperative or early stoma complications. 
Recurrent parastomal herniation was diagnosed in four patients 
(19%) of the SMART group, which was significantly lower 
(p =  0.003) in comparison to 8 patients (73%) in the control 
group. Designed as a pilot study, there are some basic limitations, 
such as missing randomization, heterogeneity of patients and 
short follow up. But this new technique could be promising in 
high risk patients and the results of an ongoing randomized trial 
(ISRCTN 94943190) in this technique should be give us more 
detailed information and conclusions.
Another ongoing multicenter RCT from France (Centre 
Hospitalier Universitaire, Amiens) comparing prophylactic 
biological mesh vs. no mesh in colorectal surgery with colos-
tomy (“Prospective, Multicenter, Randomized, Parallel Group 
Clinical Study Evaluating the Efficacy of a Biological Mesh 
(Strattice™) for the Prevention of Parastomal Hernia After 
Colorectal Surgery With Colostomy,” NCT02121743), should 
be completed by April 2016.
DiSCUSSiON/SUMMARY
The current literature supports the significant risk reduction 
of parastomal hernia development by mesh reinforcement 
of the permanent stoma at the primary operation. Based on 
the published literature, the prophylactic mesh application 
is not associated with a significant increase of mesh-specific 
complications and comorbidities such as seroma, infection 
and migration. Concerning the choice of mesh, synthetic or 
biologic prosthesis, there are only four level 1 b studies – two 
with the use of synthetic meshes in retro-muscular position (15, 
16) as well as two with biologic mesh reinforcement in sublay 
position (11, 12). The best option of mesh placement – onlay, 
sublay, or intraperitoneal – keyhole, sugarbaker, sandwich, or 
by a 3D funnel mesh type (20)  –  remains unclear and has to 
be compared in further RCT. In summary, so far now only two 
RCT (11, 12) and two case-control studies with prophylactic 
biomesh reinforcement in stoma sites are published. Both 
studies have to be looked at very critically due to limitations 
[too small numbers of patients and short follow up (11)] and 
a heterogeneity of patients regarding the different trephine 
sizes to the abdominal wall (12). However, in both RCT as well 
in the two case-control studies (13, 14), no bio-mesh related 
complication was observed. The discussion addressing the 
topic of crosslinking vs. non-crosslinking in terms of suscep-
tibility to infection and failure of remodeling (bulging) in this 
special indication remains unclear, since we do not have any 
late term results and both studies used different bio-prosthesis 
(Permacol™, Surgisis™).
Nevertheless, we have to consider that only 50% of patients will 
develop a parastomal hernia by using non-mesh techniques and 
there is a risk of overtreatment if all patients receive a prophylac-
tic mesh. So, it is mandatory to investigate which patients are at a 
significant risk of developing a parastomal hernia. In conclusion, 
it seems to be beneficial to place a mesh at the primary opera-
tion when performing a permanent stoma based on the available 
literature, which describes no increase of complications, easy 
performance, and cost-effectiveness (13).
In summary, based on the data available, the prophylactic 
placement of mesh at the index operation associated with stoma 
creation needs scientific attention in the near future.
The remaining questions concerning the choice of mesh 
material, mesh design, and most favorable anatomical location 
for the mesh have to be answered by additional well-designed 
prospective multicenter studies.
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